160
Participants
Start Date
June 26, 2023
Primary Completion Date
February 25, 2025
Study Completion Date
March 10, 2025
JZP258
0.5 g/ml calcium, magnesium, potassium, and sodium oxybates oral solution
Antwerp University Hospital (UZA), Edegem
Private Practice RESPISOM Namur, Namur
Hospital General de Castellon, Castellon
Abington Neurological Associates, LTD, Abington
Ospedale San Raffaele (San Raffaele Turro), Milan
University of Maryland Medical Center, Baltimore
Hospital Universitario Clinico San Carlos, Madrid
Advanced Respiratory and Sleep Medicine, PLLC, Huntersville
Bogan Sleep Consultants, LLC, Columbia
Velocity Clinical Research, Greenville, Greenville
Clinical Research of Rock Hill, Rock Hill
Sleep Practitioners, LLC, Macon
Florida Pediatric Research Institute, LLC, Orlando
Ocean Wellness Center, Miami
Serenity Research Center LLC, Miami
FWD Clinical Research, Boca Raton
Meris Clinical Research, LLC, Brandon
Hopital Gui de Chauliac, Montpellier
CHU de Grenoble - Hôpital Albert Michallon, Grenoble
IRCCS Istituto de Scienze Neurologiche di Bologna (ISNB), Bologna
University of Louisville, Louisville
Ohio Sleep Medicine and Neuroscience, Dublin
CHU Nantes - Hôtel Dieu, Nantes
University Hospitals Cleveland Medical Center, Cleveland
Intrepid Research, LLC, Cincinnati
Sparrow Health System, Lansing
Bryan Medical Center, Lincoln
Sleep Therapy & Research Center, San Antonio
FutureSearch Trials of Neurology, Austin
Saltzer Medical Group, Nampa
Henderson Clinical Trials LLC, Henderson
Science 37, Culver City
Long Beach Research Institute, Lakewood
M3 Wake Research, Encino
So Cal Clinical Research, Huntington Beach
SDS Clinical Trials, Inc., Santa Ana
Stanford School of Medicine, Redwood City
TriValley Sleep Center, San Ramon
OHSU Hospital, Portland
Neurocare, Inc, Newton
Azienda Ospedaliera Universitaria Policlinico Tor Vergata, Roma
Hospital Universitario Araba - Sede Santiago, Vitoria-Gasteiz
Hospital Universitari Vall d'Hebron, Barcelona
Lead Sponsor
Jazz Pharmaceuticals
INDUSTRY